To determine whether smartphone and internet assisted self-management tools can help improve medication adherence in patients with Parkinson's disease

Not Applicable

Completed

• Conditions: Nervous System Diseases; Parkinson disease; Parkinson's disease

• Registration Number: ISRCTN45824264
• Lead Sponsor: uMotif Limited (UK)

Brief Summary

1. 2014 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/25257518 2. 2017 results in: https://www.ncbi.nlm.nih.gov/pubmed/28649602

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-11-05
• Study Completion: 2014-08-31
• Last Update Posted: 12 November 2018

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 266

Inclusion Criteria

1. Adults aged 21-75 years or over diagnosed with, or with probable, idiopathic PD
2. Prescribed one or more anti-parkinsonian medications by a consultant neurologist or consultant physician or GP with specialist knowledge of movement disorders
3. English speaking and literate i.e can read, write, and speak in English and compute and solve problems at levels of proficiency necessary to function daily at job and/or daily living
4. Has access to a smartphone and/or internet on a regular (> weekly) basis in their home
5. Stable medication regime i.e. not altered within the previous month and not expected to change during the period of the trial (16 weeks)
6. Not diagnosed with dementia or significant cognitive impairment

Exclusion Criteria

1. Suspected Parkinsonism due to other causes than idiopathic PD
2. Treated with anti-parkinsonian medications (anti-cholinergics) for side effects of prolonged neuroleptic treatment
3. Diagnosed with dementia or significant cognitive impairment
4. Diagnosed with mental illness associated with psychosis ? schizophrenia, severe depression with psychosis, bipolar affective disorder
5. Detrimental illness with a short life expectancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Adherence to medication determined by Morisky Medication Adherence Scale (MMAS-8) at 16 weeks

Secondary Outcome Measures

Name	Time	Method
1. QoL determined by the Parkinson?s Disease Questionnaire-39 (PDQ-39) <br>2. Quality of consultation for PD patients (questions from Patient-Centered Questionnaire for Parkinson?s Disease [PCQ-PD]) <br>3. Non Motor Symptoms Questionnaire (NMSQuest)<br>4. Hospital Anxiety and Depression rating scale <br>5. Beliefs about Medication Questionnaire (BMQ)